Cooley LLP advised Shoreline Biosciences on the deal. Shoreline Biosciences, a biotechnology company developing immunotherapies for cancer and other serious diseases, announced its worldwide strategic collaboration with...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here